PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,953,944 | -25.2% | 128,877 | -2.3% | 0.00% | -50.0% |
| Q2 2023 | $5,287,838 | -2.3% | 131,965 | -0.5% | 0.00% | 0.0% |
| Q1 2023 | $5,410,997 | +5.5% | 132,590 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $5,126,751 | -26.8% | 132,783 | +0.8% | 0.00% | -33.3% |
| Q3 2022 | $7,004,000 | -8.9% | 131,680 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $7,686,000 | -22.8% | 131,841 | +1.0% | 0.00% | 0.0% |
| Q1 2022 | $9,962,000 | +30.3% | 130,531 | +2.7% | 0.00% | +50.0% |
| Q4 2021 | $7,648,000 | +11.0% | 127,105 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $6,887,000 | +0.2% | 122,985 | +8.6% | 0.00% | 0.0% |
| Q2 2021 | $6,875,000 | -31.1% | 113,295 | -20.4% | 0.00% | -50.0% |
| Q1 2021 | $9,974,000 | +21.1% | 142,303 | +3.4% | 0.00% | +33.3% |
| Q4 2020 | $8,237,000 | +0.4% | 137,649 | +0.9% | 0.00% | -25.0% |
| Q3 2020 | $8,201,000 | +16.3% | 136,408 | +1.5% | 0.00% | +33.3% |
| Q2 2020 | $7,053,000 | +69.5% | 134,421 | +8.4% | 0.00% | +50.0% |
| Q1 2020 | $4,160,000 | -25.7% | 124,041 | +0.4% | 0.00% | -33.3% |
| Q4 2019 | $5,599,000 | +45.3% | 123,605 | +22.1% | 0.00% | +50.0% |
| Q3 2019 | $3,854,000 | +413.2% | 101,246 | +486.5% | 0.00% | – |
| Q2 2019 | $751,000 | +17.0% | 17,263 | +2.4% | 0.00% | – |
| Q1 2019 | $642,000 | -10.5% | 16,853 | +1.2% | 0.00% | -100.0% |
| Q4 2018 | $717,000 | -6.0% | 16,652 | +7.3% | 0.00% | 0.0% |
| Q3 2018 | $763,000 | +53.8% | 15,523 | +0.2% | 0.00% | – |
| Q2 2018 | $496,000 | -3.9% | 15,494 | -6.5% | 0.00% | – |
| Q1 2018 | $516,000 | -41.2% | 16,565 | -13.8% | 0.00% | -100.0% |
| Q4 2017 | $877,000 | +18.2% | 19,221 | -2.2% | 0.00% | 0.0% |
| Q3 2017 | $742,000 | +19.7% | 19,662 | +51.4% | 0.00% | 0.0% |
| Q2 2017 | $620,000 | +10.1% | 12,985 | +5.3% | 0.00% | – |
| Q1 2017 | $563,000 | +40.4% | 12,332 | -1.4% | 0.00% | – |
| Q4 2016 | $401,000 | +36.9% | 12,503 | +43.0% | 0.00% | – |
| Q3 2016 | $293,000 | -9.0% | 8,741 | -2.7% | 0.00% | – |
| Q2 2016 | $322,000 | -20.1% | 8,985 | +16.5% | 0.00% | – |
| Q1 2016 | $403,000 | -25.2% | 7,715 | +10.6% | 0.00% | -100.0% |
| Q4 2015 | $539,000 | +86.5% | 6,975 | 0.0% | 0.00% | – |
| Q3 2015 | $289,000 | -37.0% | 6,975 | +5.5% | 0.00% | -100.0% |
| Q2 2015 | $459,000 | -19.2% | 6,612 | +5.0% | 0.00% | 0.0% |
| Q1 2015 | $568,000 | +19.8% | 6,300 | +21.7% | 0.00% | 0.0% |
| Q4 2014 | $474,000 | -9.0% | 5,176 | -2.1% | 0.00% | 0.0% |
| Q3 2014 | $521,000 | – | 5,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |